Breakthrough zygomycoses in patients receiving antifungal therapy with voriconazole.

被引：0
|
作者：
Balasubramanian, L [1 ]
Trifilio, SM [1 ]
Tallman, M [1 ]
Mehta, J [1 ]
Bennett, C [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：601S / 601S
页数：1
相关论文
共 50 条
  • [21] Antifungal prophylaxis in haematology patients: the role of voriconazole
    Hicheri, Y.
    Cook, G.
    Cordonnier, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18
  • [22] Symptom improvement in patients with onychomycosis receiving oral antifungal therapy
    Galitz, J
    Schein, JR
    Doyle, JJ
    SOUTHERN MEDICAL JOURNAL, 2002, 95 (11) : 1359 - 1360
  • [23] Bioassay for Determining Voriconazole Serum Levels in Patients Receiving Combination Therapy with Echinocandins
    Siopi, Maria
    Neroutsos, Efthymios
    Zisaki, Kalliopi
    Gamaletsou, Maria
    Pirounaki, Maria
    Tsirigotis, Panagiotis
    Sipsas, Nikolaos
    Dokoumetzidis, Aristides
    Goussetis, Evgenios
    Zerva, Loukia
    Valsami, Georgia
    Meletiadis, Joseph
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 632 - 636
  • [24] Photosensitivity in Immunocompromised Patients Receiving Long-term Therapy With Oral Voriconazole
    Antoinette Frick, Marie
    Soler-Palacin, Pere
    Martin Nalda, Andrea
    Espiau Guarner, Maria
    Figueras Nadal, Concepcio
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (05) : 480 - 481
  • [25] Pharmacogenetic of voriconazole antifungal agent in pediatric patients
    Allegra, Sarah
    Fatiguso, Giovanna
    De Francia, Silvia
    Pirro, Elisa
    Carcieri, Chiara
    Cusato, Jessica
    De Nicolo, Amedeo
    Avataneo, Valeria
    Di Perri, Giovanni
    D'Avolio, Antonio
    PHARMACOGENOMICS, 2018, 19 (11) : 913 - 925
  • [26] Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies
    Valentini, C. G.
    Candoni, A.
    Fianchi, L.
    Posteraro, B.
    Simeone, E.
    Costa, F.
    Sanguinetti, M.
    Voso, M. T.
    Caira, M.
    Fanin, R.
    Pagano, L.
    MYCOSES, 2010, 53 (01) : 89 - 92
  • [27] Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT
    Gatti, Milo
    Campoli, Caterina
    Muratore, Edoardo
    Belotti, Tamara
    Masetti, Riccardo
    Lanari, Marcello
    Viale, Pierluigi
    Pea, Federico
    MICROORGANISMS, 2024, 12 (07)
  • [28] A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis
    Biehl, Lena M.
    Vehreschild, J. Janne
    Liss, Blasius
    Franke, Bernd
    Markiefka, Birgid
    Persigehl, Thorsten
    Buecker, Vanessa
    Wisplinghoff, Hilmar
    Scheid, Christof
    Cornely, Oliver A.
    Vehreschild, Maria J. G. T.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (09) : 2634 - 2641
  • [29] Fluoride Excess and Periostitis in Transplant Patients Receiving Long-Term Voriconazole Therapy
    Wermers, Robert A.
    Cooper, Kay
    Razonable, Raymund R.
    Deziel, Paul J.
    Whitford, Gary M.
    Kremers, Walter K.
    Moyer, Thomas P.
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (05) : 604 - 611
  • [30] VORICONAZOLE AS SALVAGE THERAPY IN IMMUNOCOMPROMISED PATIENTS WITH PULMONARY ASPERGILLOSIS WHO RECEIVED FIRST LINEE ANTIFUNGAL THERAPY WITH CASPOFUNGIN
    Simeone, E.
    Candoni, A.
    Chiozzotto, M.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 71 - 71
12345